cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Kymera Therapeutics Inc
3 own
4 watching
Current Price
$33.29
$-1.58
(-4.53%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,292.36M
52-Week High
52-Week High
45.31000
52-Week Low
52-Week Low
9.60000
Average Volume
Average Volume
0.41M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization1,292.36M
icon52-Week High45.31000
icon52-Week Low9.60000
iconAverage Volume0.41M
iconDividend Yield--
iconP/E Ratio--
What does the Kymera Therapeutics Inc do?
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body s own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis, macrophage activation syndrome, general pustular psoriasis, and rheumatoid arthritis; IRAKIMiD program to treat MYD88-mutated diffuse large B cell lymphoma; STAT3 program for the treatment of hematologic malignancies and solid tumors, as well as autoimmune diseases and fibrosis; and MDM2 program to treat hematological malignancies and solid tumors. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.
Read More
How much money does Kymera Therapeutics Inc make?
News & Events about Kymera Therapeutics Inc.
Stock Options Channel
11 months ago
Investors considering a purchase of Kymera Therapeutics Inc (KYMR) shares, but cautious about paying the going market price of 22.35/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the December...
Globe Newswire
11 months ago
WATERTOWN, Mass., June 22, 2023 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines, today announced that the U.S. Food and Drug Administration (FDA...
Globe Newswire
1 year ago
Data shared today on PK/PD and safety from additional KT-333 and KT-413 patient dose escalation cohorts show target knockdown at or near levels associated with clinical efficacy in preclinical tumor models No dose limiting toxicities observed in either program KT-333 data will be presented in a ...
Globe Newswire
1 year ago
A single dose of KT-253 drives tumor regression and demonstrates differentiated pharmacology compared to small molecule inhibitor (SMI) in preclinical models of ALL and AMLWATERTOWN, Mass., June 09, 2023 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical...
Market News Video
1 year ago
In trading on Thursday, shares of Kymera Therapeutics Inc (KYMR) crossed below their 200 day moving average of 29.07, changing hands as low as 26.43 per share. Kymera Therapeutics Inc shares are currently trading down about 13.4% on the day...
Frequently Asked Questions
Frequently Asked Questions
What is Kymera Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Kymera Therapeutics Inc shares?
plus_minus_icon
How can I buy Kymera Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Kymera Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Kymera Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Kymera Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Kymera Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Kymera Therapeutics Inc?
plus_minus_icon
What percentage is Kymera Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Kymera Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$33.29
$-1.58
(-4.53%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00